Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Rossi

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Clinical Dysmorphology|December 13, 2006
WAGR syndrome: is the 'R' always justified?Cristiano Termine, Gian Parigi, Maura Rossi, et al.
Functional Neurology|June 14, 2005
Alternative therapies in the treatment of headache in childhood, adolescence and adulthoodCristiano Termine, Oreste Ferrari Ginevra, Stefano D'Arrigo, et al.
Haematologica|April 12, 2003
Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual diseaseGiuseppe Visani, Pier Paolo Piccaluga, Giovanni Martinelli, et al.
International Journal of Environmental Research and Public Health|October 13, 2021
Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. <i>Int. J. Environ. Res. Public Health</i> 2020, <i>17</i>, 9509Vittorio Fusco, Manuela Alessio, Pamela Francesca Guglielmini, et al.
Acta Clinica Belgica|November 8, 2017
Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questionsVittorio Fusco, Maura Rossi, Iolanda De Martino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 11, 2024
Bulky Isolated Adrenal Metastasis as First Presentation of Occult Hepatocellular Carcinoma (HCC) in a Patient with a Synchronous Squamous Carcinoma of the TongueMarco Lodin, Alberto Ragni, Valerio Renzelli, et al.
Expert Opinion on Pharmacotherapy|April 22, 2024
Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapyEmanuele Parodi, Maura Rossi, Achille Bottiglieri, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
The hospital care of patients with cancer: a retrospective analysis of the characteristics of their hospital stay in comparison with other medical conditionsGianmauro Numico, Cristian Zanelli, Roberto Ippoliti, et al.
Advances in Hematology|December 23, 2011
Molecular profiling of aggressive lymphomasMaura Rossi, Maria Antonella Laginestra, Anna Gazzola, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Histopathology of B-cell chronic lymphocytic leukemiaStefano A Pileri, Elena Sabattini, Claudio Agostinelli, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Clinical Dysmorphology|December 13, 2006
WAGR syndrome: is the 'R' always justified?Cristiano Termine, Gian Parigi, Maura Rossi, et al.
Functional Neurology|June 14, 2005
Alternative therapies in the treatment of headache in childhood, adolescence and adulthoodCristiano Termine, Oreste Ferrari Ginevra, Stefano D'Arrigo, et al.
Haematologica|April 12, 2003
Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual diseaseGiuseppe Visani, Pier Paolo Piccaluga, Giovanni Martinelli, et al.
International Journal of Environmental Research and Public Health|October 13, 2021
Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. <i>Int. J. Environ. Res. Public Health</i> 2020, <i>17</i>, 9509Vittorio Fusco, Manuela Alessio, Pamela Francesca Guglielmini, et al.
Acta Clinica Belgica|November 8, 2017
Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questionsVittorio Fusco, Maura Rossi, Iolanda De Martino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 11, 2024
Bulky Isolated Adrenal Metastasis as First Presentation of Occult Hepatocellular Carcinoma (HCC) in a Patient with a Synchronous Squamous Carcinoma of the TongueMarco Lodin, Alberto Ragni, Valerio Renzelli, et al.
Expert Opinion on Pharmacotherapy|April 22, 2024
Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapyEmanuele Parodi, Maura Rossi, Achille Bottiglieri, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
The hospital care of patients with cancer: a retrospective analysis of the characteristics of their hospital stay in comparison with other medical conditionsGianmauro Numico, Cristian Zanelli, Roberto Ippoliti, et al.
Advances in Hematology|December 23, 2011
Molecular profiling of aggressive lymphomasMaura Rossi, Maria Antonella Laginestra, Anna Gazzola, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Histopathology of B-cell chronic lymphocytic leukemiaStefano A Pileri, Elena Sabattini, Claudio Agostinelli, et al.
Pageof 8